Monday, January 21, 2019

Health

AbbVie’s cancer drug fails to meet main goal in late-stage study

FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18,...

Samsung Bioepis biosimilar to Roche’s Herceptin wins FDA nod

FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22,...

Samsung Bioepis-Merck biosimilar to Roche’s Herceptin wins FDA nod

FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22,...

For heart failure patients in hospital, flu boosts risk of complications,...

(Reuters Health) - When people with heart failure are hospitalized, having influenza is tied to greater odds of respiratory and kidney complications and...

Lilly cancer drug fails key trial, will no longer be prescribed

(Reuters) - Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient...

Study links opioid epidemic to painkiller marketing

(Reuters Health) - Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses. In...

Lilly’s cancer therapy Lartruvo fails study, shares drop

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker...

Lilly’s cancer therapy Lartruvo fails to meet main goal in late-stage...

(Reuters) - Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial...

Immunomedics’ cancer treatment fails to win accelerated approval from the FDA

(Reuters) - Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment,...

RECOMMENDED VIDEOS

POPULAR